The triple receptor activity tends to produce a slightly different GI symptom pattern than tirzepatide, with more delayed gastric symptoms and less reflux
R., Balasubramanian, R., Chauhan, R., Priyakumar, U
doi: 10.1159/000054072 12ShoabSS, PorterJ, ScurrJH, Coleridge-SmithPD
Although these two drugs were originally developed to improve glycemic control in people with type 2 diabetes, they simultaneously cause significant weight loss in these patients, without too many major side effects, and could therefore represent a new therapeutic strategy for the normalization of body weight
Pulmonary Aspiration Because food stays in the stomach longer, there is a small risk of pulmonary aspiration